businesspress24.com - BioElectronics Announces ActiPatch(R) Available on Amazon
 

BioElectronics Announces ActiPatch(R) Available on Amazon

ID: 1485760

(firmenpresse) - FREDERICK, MD -- (Marketwired) -- 02/09/17 -- BioElectronics Corporation (OTC PINK: BIEL), the maker of advanced pain management medical devices, today announced that ActiPatch® Musculoskeletal Pain Therapy device is now available on the US Amazon.com. ActiPatch is the leading nonprescription pain therapy in the United Kingdom with over 300 reviews that rate the device 4.5 Stars out of 5 on Walgreens/Boots website

ActiPatch is for the 100+ million US chronic pain sufferers. The easy to wear drug-free medical device provides 720-hours (90, 8-hour treatments) of on/off therapy for $29.95. ActiPatch provides:

Impressive Efficacy

No harmful side effects

A 50% Reduction in Medication Use, including opioids

Exceptional Consumer Acceptance

Demonstrated Marketability

Safe adjunctive or alternative therapy to pain killers, including narcotics.

The Amazon website and the Company''s website have available the Company''s Award Winning Try & Tell 7-Day Trial Marketing product for $9.95. The 24/7 Trial Device introduces consumers to significant long-lasting pain relief that allows a full night''s sleep and restoration of daily activities without any harmful side effects.

"I expect the resounding success that we''ve had in the United Kingdom to be mirrored in the United States," says Chris Russell, VP of Marketing at BioElectronics. "We are consistently a top selling analgesic device for retailers like Amazon in the UK. Now with US FDA market clearance, we anticipate similar success in the US."



BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; and Allay® Menstrual Pain Therapy. For more information, please visit .







BioElectronics Corporation
301-874-4980

4539 Metropolitan Court
Frederick, MD 21704

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  CannaRoyalty Reaches 30% Revenue Royalty with Oregon Processor Rich Extracts
Advantis Corp. Taking Steps to Become SEC Fully-Reporting Company
Bereitgestellt von Benutzer: Marketwired
Datum: 09.02.2017 - 08:05 Uhr
Sprache: Deutsch
News-ID 1485760
Anzahl Zeichen: 3831

contact information:
Contact person:
Town:

FREDERICK, MD


Phone:

Kategorie:

Alternative


Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:


Diese Pressemitteilung wurde bisher 188 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"BioElectronics Announces ActiPatch(R) Available on Amazon
"
steht unter der journalistisch-redaktionellen Verantwortung von

BioElectronics Corporation (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von BioElectronics Corporation



 

Who is online

All members: 10 563
Register today: 2
Register yesterday: 2
Members online: 0
Guests online: 79


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.